Compare Medtronic PLC (MDT) vs Meta Platforms Inc (META) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Meta Platforms Inc — how do they compare? Medtronic PLC trades at $82.47 (market cap $106.61B), while Meta Platforms Inc trades at $648 (market cap $1.64T). The key difference: Meta Platforms Inc is far larger — about 15.4× Medtronic PLC's market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | META | |
|---|---|---|
Market Cap | $106.61B | $1.64T |
Sector | Health | Media |
52-Week High | $105.35 | $790.00 |
52-Week Low | $73.75 | $525.72 |
Enterprise Value | $125.36B | $1.65T |
Dividend Yield | 3.46% | 0.33% |
Volume | — | 24,093,972 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Meta Platforms (META) trades at $646.96, up 0.15% with a bullish technical signal supported by moving averages. The company demonstrates strong fundamentals with $201B revenue in 2025, 32.84% net margin, and consistent earnings beats. Recent AI developments including Muse Spark launch and a $21B CoreWeave deal highlight growth initiatives. Technical indicators show support at $631 and resistance at $657, with RSI in neutral territory suggesting balanced momentum.
Outlook remains positive with 79% analyst buy ratings and $817 consensus target offering 26% upside. Key opportunities include AI monetization and revenue growth to $215B in 2026. Risks involve ongoing youth addiction lawsuits, regulatory scrutiny, and high capital expenditures. Institutional ownership trends show continued confidence with recent stake increases by American National Bank.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →
